The authors sought to examine the impact of the K-variant of butyrylcholinesterase (BCHE-K) carrier status on age-at-diagnosis of Alzheimer disease (AD) in APOE4 carriers. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.